vs

Side-by-side financial comparison of PEOPLES FINANCIAL SERVICES CORP. (PFIS) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

PEOPLES FINANCIAL SERVICES CORP. is the larger business by last-quarter revenue ($46.8M vs $35.5M, roughly 1.3× RECURSION PHARMACEUTICALS, INC.). PEOPLES FINANCIAL SERVICES CORP. runs the higher net margin — 27.8% vs -304.2%, a 332.1% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs 5.8%). PEOPLES FINANCIAL SERVICES CORP. produced more free cash flow last quarter ($43.3M vs $-47.3M). Over the past eight quarters, RECURSION PHARMACEUTICALS, INC.'s revenue compounded faster (60.5% CAGR vs 43.5%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

PFIS vs RXRX — Head-to-Head

Bigger by revenue
PFIS
PFIS
1.3× larger
PFIS
$46.8M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+675.9% gap
RXRX
681.7%
5.8%
PFIS
Higher net margin
PFIS
PFIS
332.1% more per $
PFIS
27.8%
-304.2%
RXRX
More free cash flow
PFIS
PFIS
$90.7M more FCF
PFIS
$43.3M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
RXRX
RXRX
Annualised
RXRX
60.5%
43.5%
PFIS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PFIS
PFIS
RXRX
RXRX
Revenue
$46.8M
$35.5M
Net Profit
$12.0M
$-108.1M
Gross Margin
59.8%
Operating Margin
31.5%
-304.8%
Net Margin
27.8%
-304.2%
Revenue YoY
5.8%
681.7%
Net Profit YoY
96.7%
39.6%
EPS (diluted)
$1.20
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PFIS
PFIS
RXRX
RXRX
Q4 25
$46.8M
$35.5M
Q3 25
$46.7M
$5.2M
Q2 25
$48.4M
$19.2M
Q1 25
$45.8M
$14.7M
Q4 24
$44.2M
$4.5M
Q3 24
$45.0M
$26.1M
Q2 24
$22.5M
$14.4M
Q1 24
$22.7M
$13.8M
Net Profit
PFIS
PFIS
RXRX
RXRX
Q4 25
$12.0M
$-108.1M
Q3 25
$15.2M
$-162.3M
Q2 25
$17.0M
$-171.9M
Q1 25
$15.0M
$-202.5M
Q4 24
$6.1M
$-178.9M
Q3 24
$-4.3M
$-95.8M
Q2 24
$3.3M
$-97.5M
Q1 24
$3.5M
$-91.4M
Gross Margin
PFIS
PFIS
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
-4.9%
Q1 25
-48.0%
Q4 24
-181.4%
Q3 24
53.7%
Q2 24
36.2%
Q1 24
19.1%
Operating Margin
PFIS
PFIS
RXRX
RXRX
Q4 25
31.5%
-304.8%
Q3 25
40.4%
-3327.6%
Q2 25
42.2%
-916.8%
Q1 25
39.8%
-1297.9%
Q4 24
13.2%
-4042.4%
Q3 24
-11.1%
-377.1%
Q2 24
16.5%
-697.4%
Q1 24
17.4%
-698.4%
Net Margin
PFIS
PFIS
RXRX
RXRX
Q4 25
27.8%
-304.2%
Q3 25
32.7%
-3135.3%
Q2 25
35.0%
-894.2%
Q1 25
32.8%
-1373.3%
Q4 24
15.8%
-3935.5%
Q3 24
-9.6%
-367.5%
Q2 24
14.6%
-676.6%
Q1 24
15.3%
-662.4%
EPS (diluted)
PFIS
PFIS
RXRX
RXRX
Q4 25
$1.20
$-0.17
Q3 25
$1.51
$-0.36
Q2 25
$1.68
$-0.41
Q1 25
$1.49
$-0.50
Q4 24
$0.47
$-0.56
Q3 24
$-0.43
$-0.34
Q2 24
$0.46
$-0.40
Q1 24
$0.49
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PFIS
PFIS
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$519.8M
$1.1B
Total Assets
$5.3B
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PFIS
PFIS
RXRX
RXRX
Q4 25
$743.3M
Q3 25
$659.8M
Q2 25
$525.1M
Q1 25
$500.5M
Q4 24
$594.4M
Q3 24
$427.6M
Q2 24
$474.3M
Q1 24
$296.3M
Total Debt
PFIS
PFIS
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
PFIS
PFIS
RXRX
RXRX
Q4 25
$519.8M
$1.1B
Q3 25
$509.3M
$1.0B
Q2 25
$494.1M
$919.1M
Q1 25
$481.9M
$933.9M
Q4 24
$468.9M
$1.0B
Q3 24
$475.1M
$524.6M
Q2 24
$340.8M
$584.4M
Q1 24
$340.0M
$401.2M
Total Assets
PFIS
PFIS
RXRX
RXRX
Q4 25
$5.3B
$1.5B
Q3 25
$5.2B
$1.4B
Q2 25
$5.1B
$1.3B
Q1 25
$5.0B
$1.3B
Q4 24
$5.1B
$1.4B
Q3 24
$5.4B
$726.5M
Q2 24
$3.6B
$775.9M
Q1 24
$3.7B
$557.8M
Debt / Equity
PFIS
PFIS
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PFIS
PFIS
RXRX
RXRX
Operating Cash FlowLast quarter
$54.3M
$-46.1M
Free Cash FlowOCF − Capex
$43.3M
$-47.3M
FCF MarginFCF / Revenue
92.7%
-133.1%
Capex IntensityCapex / Revenue
23.4%
3.5%
Cash ConversionOCF / Net Profit
4.53×
TTM Free Cash FlowTrailing 4 quarters
$73.4M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PFIS
PFIS
RXRX
RXRX
Q4 25
$54.3M
$-46.1M
Q3 25
$15.2M
$-117.4M
Q2 25
$13.9M
$-76.4M
Q1 25
$9.1M
$-132.0M
Q4 24
$34.7M
$-115.4M
Q3 24
$21.9M
$-59.2M
Q2 24
$1.7M
$-82.2M
Q1 24
$3.2M
$-102.3M
Free Cash Flow
PFIS
PFIS
RXRX
RXRX
Q4 25
$43.3M
$-47.3M
Q3 25
$13.0M
$-117.6M
Q2 25
$8.5M
$-79.6M
Q1 25
$8.6M
$-133.8M
Q4 24
$32.1M
$-116.7M
Q3 24
$17.6M
$-63.8M
Q2 24
$1.3M
$-83.4M
Q1 24
$3.0M
$-109.0M
FCF Margin
PFIS
PFIS
RXRX
RXRX
Q4 25
92.7%
-133.1%
Q3 25
27.9%
-2272.5%
Q2 25
17.6%
-413.9%
Q1 25
18.7%
-907.4%
Q4 24
72.8%
-2567.7%
Q3 24
39.1%
-244.6%
Q2 24
6.0%
-578.5%
Q1 24
13.3%
-789.9%
Capex Intensity
PFIS
PFIS
RXRX
RXRX
Q4 25
23.4%
3.5%
Q3 25
4.7%
4.7%
Q2 25
11.1%
16.4%
Q1 25
1.1%
12.4%
Q4 24
5.8%
28.6%
Q3 24
9.6%
17.5%
Q2 24
1.8%
8.2%
Q1 24
1.0%
48.2%
Cash Conversion
PFIS
PFIS
RXRX
RXRX
Q4 25
4.53×
Q3 25
1.00×
Q2 25
0.82×
Q1 25
0.60×
Q4 24
5.70×
Q3 24
Q2 24
0.53×
Q1 24
0.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons